The optimal therapy strategy for epidermal growth factor receptor‐mutated non‐small cell lung cancer patients with brain metastasis: A real‐world study from Taiwan

The optimal therapy strategy for epidermal growth factor receptor‐mutated non‐small cell lung cancer patients with brain metastasis: A real‐world study from Taiwan

Abstract Background The treatment options for epidermal growth factor receptor (EGFR)‐mutated non‐small cell lung cancer (NSCLC) with brain metastases (BMs) include EGFR‐tyrosine kinase inhibitors (TKIs), stereotactic radiosurgery (SRS), whole‐brain radiotherapy, brain surgery, and antiangiogenesis...

Full description

Bibliographic Details
Main Authors: Wen‐Chien Cheng, Yi‐Cheng Shen, Chun‐Ru Chien, Wei‐Chih Liao, Chia‐Hung Chen, Te‐Chun Hsia, Chih‐Yeh Tu, Hung‐Jen Chen
Format: Article
Language:English
Published: Wiley 2022-05-01
Series:Thoracic Cancer
Subjects:
brain metastasis
epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors
graded prognostic assessment for lung cancer using molecular markers (lung‐mol GPA)
stereotactic radiosurgery
Online Access:https://doi.org/10.1111/1759-7714.14423

Internet

https://doi.org/10.1111/1759-7714.14423

Similar Items